Merck KGaA Share Price

Equities

MRK

DE0006599905

Pharmaceuticals

Real-time Estimate Tradegate 09:55:56 15/07/2024 BST 5-day change 1st Jan Change
154 EUR -0.19% Intraday chart for Merck KGaA +2.18% +7.15%

Financials

Sales 2024 * 21.3B 23.2B 1,788B Sales 2025 * 22.55B 24.55B 1,892B Capitalization 67.06B 73.03B 5,628B
Net income 2024 * 2.98B 3.25B 250B Net income 2025 * 3.52B 3.84B 296B EV / Sales 2024 * 3.45 x
Net Debt 2024 * 6.44B 7.01B 540B Net Debt 2025 * 4.63B 5.04B 389B EV / Sales 2025 * 3.18 x
P/E ratio 2024 *
22.5 x
P/E ratio 2025 *
18.9 x
Employees 62,345
Yield 2024 *
1.51%
Yield 2025 *
1.65%
Free-Float 29.71%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Merck KGaA

1 day+0.28%
1 week+2.61%
Current month+0.19%
1 month-9.46%
3 months+1.87%
6 months+7.45%
Current year+7.60%
More quotes
1 week
147.40
Extreme 147.4
155.45
1 month
147.40
Extreme 147.4
172.35
Current year
140.50
Extreme 140.5
176.25
1 year
134.30
Extreme 134.3
176.25
3 years
134.30
Extreme 134.3
231.50
5 years
76.22
Extreme 76.22
231.50
10 years
61.05
Extreme 61.05
231.50
More quotes
Managers TitleAgeSince
Chief Executive Officer 63 12/07/20
Director of Finance/CFO 56 31/07/14
Director of Finance/CFO 54 25/04/19
Members of the board TitleAgeSince
Director/Board Member - -
Director/Board Member 61 30/04/12
Director/Board Member 62 31/12/90
More insiders
Date Price Change Volume
15/07/24 154.4 +0.10% 12 085
12/07/24 154.2 +0.59% 243,634
11/07/24 153.4 +2.82% 285,533
10/07/24 149.2 -0.37% 267,632
09/07/24 149.7 -0.93% 234,734

Delayed Quote Xetra, July 15, 2024 at 08:27 am

More quotes
Merck KGaA is one of the world's leading pharmaceutical and chemical groups. Net sales break down by family of products as follows: - solutions and products for scientific and biotechnological research (44.2%); - pharmaceutical products (38.4%): prescription drugs for the treatment of diabetes, cancer, multiple sclerosis, infertility, cardiovascular disease, central nervous system disorders, inflammatory disorders, etc.; - performance materials for the electronics industry (17.4%): semiconductor materials, liquid crystals, pigments and additives, carbon-based organic materials, etc. Net sales are distributed geographically as follows: Germany (4.8%), Europe (24%), China (12.9%), Asia/Pacific (20.1%), the United States (26.8%), North America (1.6%), Latin America (6.3%), Middle East and Africa (3.5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
A
More Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
16
Last Close Price
154.2 EUR
Average target price
183 EUR
Spread / Average Target
+18.64%
Consensus